Vanda Pharmaceuticals (VNDA)
Develops and commercializes specialty therapies across psychiatric, sleep, MS, and motion-sickness markets.
$5.21
After hours0.00 (0.00%)
At close$5.21(+1.07%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$0.72
Revenue estimate
$69.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Oct '25Feb '26May '26Aug '26Nov '26
Reported−$0.08−$0.50−$0.46−$0.38−$2.39−$0.82−$1.04Pending
Estimate−$0.14−$0.55−$0.34−$0.31−$2.18−$0.53−$0.58−$0.72
Surprise+42.9%+9.1%−35.3%−22.6%−9.6%−54.7%−78.5%—
RevenueReportedEstimate
Feb '25May '25Jul '25Oct '25Feb '26May '26Aug '26Nov '26
Reported$53.2M$50.0M$52.6M$56.3M$57.2M$51.7M$50.5MPending
Estimate$52.3M$45.1M$58.7M$59.3M$59.3M$55.0M$61.9M$69.3M
Surprise+1.8%+10.9%−10.5%−5.1%−3.5%−5.9%−18.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.08 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.28 | — | — |
| Mar 2027 | −$0.44 | — | — |
| Dec 2026 | −$0.49 | — | — |
| Nov 2026 | −$0.72 | — | — |
| Aug 2026 | −$0.58 | −$1.04 | −78.5% |
| May 2026 | −$0.53 | −$0.82 | −54.7% |
| Feb 2026 | −$2.18 | −$2.39 | −9.6% |
| Oct 2025 | −$0.31 | −$0.38 | −22.6% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.08 | — | — | $91.5M | — | — | — |
| Sep 2027 | −$0.19 | — | — | $86.5M | — | — | — |
| Jun 2027 | −$0.28 | — | — | $82.0M | — | — | — |
| Mar 2027 | −$0.44 | — | — | $77.5M | — | — | — |
| Dec 2026 | −$0.49 | — | — | $77.1M | — | — | — |
| Nov 4, 2026 | −$0.72 | — | — | $69.3M | — | — | — |
| Aug 5, 2026 | −$0.58 | −$1.04 | −78.5% | $61.9M | $50.5M | −18.4% | +0.6% |
| May 6, 2026 | −$0.53 | −$0.82 | −54.7% | $55.0M | $51.7M | −5.9% | −14.1% |
| Feb 11, 2026 | −$2.18 | −$2.39 | −9.6% | $59.3M | $57.2M | −3.5% | −17.6% |
| Oct 29, 2025 | −$0.31 | −$0.38 | −22.6% | $59.3M | $56.3M | −5.1% | −20.2% |
| Jul 31, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 13, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 7, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Jul 27, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 8, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Jul 28, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 10, 2021 | |||||||
| Oct 28, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Jul 31, 2019 | |||||||
| May 1, 2019 | |||||||
| Feb 13, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 2, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 2, 2017 | |||||||
| Feb 15, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Jul 27, 2016 | |||||||
| May 4, 2016 | |||||||
| Feb 10, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Jul 29, 2015 |